Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009

被引:20
|
作者
Lindsey, Nicole P. [1 ]
Staples, J. Erin [1 ]
Jones, James F. [2 ]
Sejvar, James J. [1 ]
Griggs, Anne [1 ]
Iskander, John [3 ]
Miller, Elaine R. [4 ]
Fischer, Marc [1 ]
机构
[1] Ctr Dis Control & Prevent, Arboviral Dis Branch, Ft Collins, CO 80521 USA
[2] CDC, Chron Viral Dis Branch, Atlanta, GA 30333 USA
[3] CDC, Off Associate Director Sci, Atlanta, GA 30333 USA
[4] CDC, Immunizat Safety Off, Atlanta, GA 30333 USA
关键词
Japanese encephalitis; Vaccine; Adverse event; VAERS; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ALLERGIC REACTIONS; CASE-DEFINITION; SYSTEM VAERS; SAFETY; IMMUNIZATION; GUIDELINES; COLLECTION; SURVEILLANCE;
D O I
10.1016/j.vaccine.2010.10.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We reviewed adverse events following receipt of inactivated mouse brain-derived Japanese encephalitis (JE) vaccine reported to the U.S. Vaccine Adverse Event Reporting System (VAERS) from 1999 to 2009. During this period, VAERS received 300 adverse event reports following JE vaccination (24 per 100,000 doses distributed); 106 (35%) were classified as hypersensitivity reactions (8.4 per 100,000 doses) and four (1%) were classified as neurologic events (0.3 per 100,000 doses). Twenty-three (8%) reports described serious adverse events (1.8 per 100,000 doses distributed). There were no reports of encephalitis, meningitis, or Guillain-Barre syndrome. As reported previously, hypersensitivity reactions were common among persons receiving inactivated mouse brain-derived JE vaccine. Published by Elsevier Ltd.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 50 条
  • [41] Guillain-Barre syndrome after vaccination in United States - A report from the CDC/FDA Vaccine Adverse Event Reporting System
    Souayah, Nizar
    Nasar, Abu
    Suri, M. Fareed K.
    Qureshi, Adnan I.
    VACCINE, 2007, 25 (29) : 5253 - 5255
  • [42] A cluster analysis of serious adverse event reports after human papillomavirus (HPV) vaccination in Danish girls and young women, September 2009 to August 2017
    Ward, Daniel
    Thorsen, Nicklas Myrthue
    Frisch, Morten
    Valentiner-Branth, Palle
    Molbak, Kare
    Hviid, Anders
    EUROSURVEILLANCE, 2019, 24 (19): : 5 - 14
  • [43] Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination
    Williams, S. Elizabeth
    Pahud, Barbara A.
    Vellozzi, Claudia
    Donofrio, Peter D.
    Dekker, Cornelia L.
    Halsey, Neal
    Klein, Nicola P.
    Baxter, Roger P.
    Marchant, Colin D.
    LaRussa, Philip S.
    Barnett, Elizabeth D.
    Tokars, Jerome I.
    McGeeney, Brian E.
    Sparks, Robert C.
    Aukes, Laurie L.
    Jakob, Kathleen
    Coronel, Silvia
    Sejvar, James J.
    Slade, Barbara A.
    Edwards, Kathryn M.
    VACCINE, 2011, 29 (46) : 8302 - 8308
  • [44] Adolescent Vaccination-Coverage Levels in the United States: 2006-2009
    Stokley, Shannon
    Cohn, Amanda
    Dorell, Christina
    Hariri, Susan
    Yankey, David
    Messonnier, Nancy
    Wortley, Pascale M.
    PEDIATRICS, 2011, 128 (06) : 1078 - 1086
  • [45] Adverse reactions following MPox (monkeypox) vaccination: An overview from the Dutch and global adverse event reporting systems
    van der Boom, Meiwen
    van Hunsel, Florence
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (11) : 3302 - 3310
  • [46] Kikuchi–Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis
    Toru Watanabe
    Hideki Hashidate
    Yutaka Hirayama
    Yasushi Iinuma
    European Journal of Pediatrics, 2012, 171 : 1409 - 1411
  • [47] Comparative frequency of specified adverse events following Vero cell culture-derived Japanese encephalitis and Vi capsular polysaccharide typhoid vaccines in US military personnel, July 2011-August 2019
    Seshadri, Srihari
    Martin, Stacey W.
    Hills, Susan L.
    Collins Jr, Limone C.
    VACCINE, 2023, 41 (09) : 1537 - 1540
  • [48] Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV®) in Taiwan, 2017-18
    Ma, Hsuan-Yin
    Lai, Chung-Chih
    Chiu, Nan-Chang
    Lee, Ping-Ing
    VACCINE, 2020, 38 (33) : 5219 - 5222
  • [49] Net Costs Due to Seasonal Influenza Vaccination - United States, 2005-2009
    Carias, Cristina
    Reed, Carrie
    Kim, Inkyu K.
    Foppa, Ivo M.
    Biggerstaff, Matthew
    Meltzer, Martin I.
    Finelli, Lyn
    Swerdlow, David L.
    PLOS ONE, 2015, 10 (07):
  • [50] Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
    Sonawane, Kalyani
    Lin, Yueh-Yun
    Damgacioglu, Haluk
    Zhu, Yenan
    Fernandez, Maria E.
    Montealegre, Jane R.
    Cazaban, Cecilia Ganduglia
    Li, Ruosha
    Lairson, David R.
    Lin, Ying
    Giuliano, Anna R.
    Deshmukh, Ashish A.
    JAMA NETWORK OPEN, 2021, 4 (09)